| DaVita is a healthcare provider focused on transforming care delivery to improve quality of life for patients. Co.'s United States dialysis business provides kidney dialysis services for patients suffering from end stage renal disease (ESRD). Co.'s dialysis services include outpatient hemodialysis services, hospital inpatient hemodialysis services, home-based dialysis services, ESRD laboratory services, and management services. Co.'s ancillary services and strategic initiatives businesses include integrated kidney care services, physician services, ESCO joint ventures, and clinical research programs, as well as its international operations. |
When researching a stock like DaVita, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from DVA Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for DVA stock — the real life supply and demand for the stock over time — and examines that data in different ways. One of those ways is to calculate a Simpe Moving Average ("SMA") by looking back a certain number of days. One of the most popular "longer look-backs" is the DVA 200 day moving average ("DVA 200 DMA"), while one of the most popular "shorter look-backs" is the DVA 50 day moving average ("DVA 50 DMA"). A chart showing both of these popular moving averages is shown on this page for DaVita.